A new research paper titled "Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health" has been published in Oncotarget.
Feb 28, 2024
0
0
Young people could be spared from going blind by a new genetic risk tool that could also help diagnose multiple sclerosis (MS) earlier, to start effective treatments.
Feb 28, 2024
0
32
Even as it's become clear that an inherited susceptibility to some cancers is more common than once thought, genetic testing of family members of cancer patients hasn't increased as much as experts had hoped. A new study ...
Feb 27, 2024
0
0
UC Santa Barbara researchers and collaborators in Colombia, Brazil and Germany are progressing toward an understanding of mechanisms that underlie Alzheimer's disease, in particular an early-onset, genetic form that has afflicted ...
Feb 27, 2024
0
36
A doctor at the Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, in Philadelphia, found that a patient at the center had experienced a false positive urine test after taking empagliflozin, an SGLT2 ...
In collaboration with their colleagues at the Donders Institute, researchers at the Netherlands Institute for Neuroscience have developed a simulator that enables artificial visual observations for research into visual prostheses. ...
Feb 27, 2024
0
35
Recent tracking rule changes led to a significant increase in reported Lyme disease cases in the U.S.
Feb 26, 2024
0
0
A reusable vest that can map the electric impulses of the heart in fine detail could detect abnormalities from a potentially fatal heart disease much earlier than is currently possible, suggests a new study led by UCL researchers.
Feb 26, 2024
0
0
A study of people with obstructive sleep apnea suggests that high CPAP pressures may explain why the machines do not lower a patient's risk of heart disease, which is about two to three times higher than average.
Feb 26, 2024
0
0
A new University of Kentucky Markey Cancer Center study published in JCO Precision Oncology demonstrates a feasible way to expand germline genetic testing for patients with cancer.
Feb 26, 2024
0
0
